AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10817010
Drug: Continuous hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous hormone replacement therapy alone (Group A)
Trial: 10817010
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of a half dose hormone replacement therapy and anxiolytic drug (Group B)
Trial: 1508382
Drug: Calcium folinate
RxNorm normalized name: Calcium folinate
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Calcium folinate (Citofolin Bracco S.p.A.) 15 mg/day per os starting from the 12th or 20th week of gestation
Trial: 29446069
Drug: ACT-541468 (5-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT-541468 (5-200 mg single oral dose)
Trial: 29446069
Drug: ACT-541468 (≥25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT-541468 (≥25 mg)
Trial: 17917556
Drug: Venlafaxine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (mean dose 165 mg/day, SD=73.8; range 75-300 mg)
Trial: 17917556
Drug: Paroxetine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (mean dose 26 mg/day, SD=15.04; range 10-60 mg)
Trial: 19610037
Drug: Herbal preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal preparations
Trial: 7480525
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment (four different compounds)
Trial: 2265308
Drug: herbal yeast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: herbal yeast food supplement
Trial: 299462
Drug: Prostaglandin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostaglandin (20 mg) and hypertonic saline (NaCl 5 and 10 g) with oxytocin
Trial: 27299887
Drug: DCS therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DCS therapy (docetaxel at 40 mg/m2, cisplatin at 60 mg/m2 on day 1, S-1 at 40 mg/m2 twice daily for 2 weeks) followed by gastrectomy with D2 plus para-aortic nodal dissection
Trial: 25958716
Drug: Oral chelated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral chelated zinc with standard treatment (oral prednisolone)
Trial: 25958716
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (oral prednisolone) alone
Trial: 23637065
Drug: Cocoa with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa with skimmed milk intervention (40 g/day of cocoa powder with 500 mL skimmed milk)
Trial: 23637065
Drug: Skimmed milk
RxNorm normalized name: Calcium fortified skimmed milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skimmed milk intervention (500 mL/day of skimmed milk)
Trial: 21068698
Drug: Thrombomodulin alfa
RxNorm normalized name: Thrombomodulin Alfa
DrugBank: Thrombomodulin Alfa (DB05777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombomodulin alfa (TM‐α) 0.06 mg·kg for 30 min once daily for 6 days
Trial: 21068698
Drug: Heparin 8
RxNorm normalized name: Heparine
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin 8 U·kg·h for 24 h for 6 days
Trial: 17061634
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose hydrocortisone supplementation (Group C)
Trial: 15557490
Drug: Interferon beta-1b
RxNorm normalized name: Interferon Beta-1B
DrugBank: Interferon beta-1b (DB00068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta-1b (IFNB-1b) at a dosage of 8 MIU (250 mcg)
Trial: 9706832
Drug: 6-week lisinopril
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 6-week lisinopril treatment
Trial: 30801373
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (observational cohort)
Trial: 30801373
Drug: Nonoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoperative treatment (observational cohort)
Trial: 30801373
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (overall responder analysis)
Trial: 30170285
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside (SNP) infusion (0.5 μg/kg per min for 4 hours)
Trial: 11677003
Drug: Gabapentin (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (1200 mg)
Trial: 26313650
Drug: Δ9‐THC (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Δ9‐THC (5 mg)
Trial: 26313650
Drug: Δ9‐THC (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Δ9‐THC (15 mg)
Trial: 26313650
Drug: Δ9‐THC (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Δ9‐THC (30 mg)
Trial: 22785500
Drug: 0.10 mg
RxNorm normalized name: povidone-iodine 0.10 mg in 1 mL TOPICAL SOLUTION [Povidone Iodine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.10 mg nor-β-CFT
Trial: 22785500
Drug: 0.20 mg
RxNorm normalized name: FENTANYL 10.20 mg in 1 [USP'U] TRANSDERMAL PATCH [Fentanyl]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.20 mg nor-β-CFT
Trial: 22785500
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg nor-β-CFT
Trial: 22785500
Drug: 0.30 mg
RxNorm normalized name: Corona Multi-Purpose 0.30 MG/MG Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.30 mg nor-β-CFT
Trial: 22785500
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (0.10 mg nor-β-CFT)
Trial: 20124183
Drug: Pertuzumab 420
RxNorm normalized name: pertuzumab 420 MG in 14 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pertuzumab 420 mg (arm A)
Trial: 20124183
Drug: Pertuzumab 1,050
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pertuzumab 1,050 mg (arm B)
Trial: 8450517
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (4.55 g/day of EPA and DHA)
Trial: 8450517
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg twice daily) added to fish oil
Trial: 8450517
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg twice daily) added to placebo
Trial: 2429687
Drug: Citanest with
RxNorm normalized name: Citanest
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citanest with Octapressin (prilocaine 3% with 0.03 i.u./ml. of felypressin)
Trial: 3356203
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of subcutaneous histamine and oral H2-antihistaminics (ranitidine or cimetidine)
Trial: 28593326
Drug: Dexmedetomidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine infusion (0.5 µg/kg/h) during surgery and up to 2 hours in the recovery room
Trial: 21697589
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (intense occupational therapy or non-specific interactive games)
Trial: 19097714
Drug: Tibolone (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone (1.25 mg/d)
Trial: 15232803
Drug: Remifentanil, 5
RxNorm normalized name: Remifentanil, 50 mcg/mL-NaCl 0.9% intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil, 5 microg/kg with glycopyrrolate, 0.2 mg
Trial: 15232803
Drug: Fentanyl, 20
RxNorm normalized name: FentaNYL, 200 mcg buccal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl, 20 microg/kg with glycopyrrolate, 0.2 mg
Trial: 11520836
Drug: Single infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single infusion of 5 mg/kg liposomal amphotericin B (n=46)
Trial: 11520836
Drug: Daily infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily infusions of 1 mg/kg liposomal amphotericin B for five days (n=45)
Trial: 3446803
Drug: Propranolol (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (120 mg oral dose)
Trial: 30021457
Drug: ASAP intervention
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ASAP intervention program plus treatment as usual
Trial: 26290106
Drug: Intravenous 2
RxNorm normalized name: Premarin Intravenous 25 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 2 μg·kg(‐1)·min(‐1) dopamine
Trial: 23331565
Drug: Sublingual allergen-specific
RxNorm normalized name: American house dust mite allergenic extract / European house dust mite allergenic extract Sublingual Tablet [Odactra]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual allergen-specific immunotherapy (SLIT) with Staloral 300R, Stallergenes, France
Trial: 16987170
Drug: Riluzole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riluzole (100 mg b.i.d.)
Trial: 11475269
Drug: Repaglinide 1
RxNorm normalized name: repaglinide 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repaglinide 1 mg
Trial: 11475269
Drug: Repaglinide 4
RxNorm normalized name: Repaglinide
DrugBank: Repaglinide (DB00912)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Repaglinide 4 mg
Trial: 9186283
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (TU; 120 mg/d orally for 2 months)
Trial: 1488998
Drug: Subcutaneous rHuEPO
RxNorm normalized name: GlycoPEGylated™rHuEPO
DrugBank: NE-180 (DB05619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous rHuEPO (150 U/kg/week in three divided doses)
Trial: 1488998
Drug: Intravenous rHuEPO
RxNorm normalized name: GlycoPEGylated™rHuEPO
DrugBank: NE-180 (DB05619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous rHuEPO (150 U/kg/week in three divided doses)
Trial: 1488998
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (subcutaneous and intravenous)
Trial: 27870694
Drug: Intrasession concurrent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrasession concurrent aerobic before strength training (GAS: n = 39)
Trial: 27870694
Drug: Intrasession concurrent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrasession concurrent aerobic after strength training (GSA: n = 45)
Trial: 24468428
Drug: Fenbendazole treatment
RxNorm normalized name: Fenbendazole
DrugBank: Fenbendazole (DB11410)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenbendazole treatment group (623 cows)
Trial: 15305160
Drug: Temozolomide as
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide as single agent
Trial: 15305160
Drug: Temozolomide-based chemotherapy
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide-based chemotherapy (all groups)
Trial: 11641669
Drug: Oxytocin administration
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin administration before placental delivery
Trial: 11641669
Drug: Oxytocin administration
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin administration after placental delivery
Trial: 9852693
Drug: Bolus administration
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus administration of mexiletine 2 mg.kg‐1
Trial: 9852693
Drug: Bolus administration
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus administration of mexiletine 1 mg.kg‐1 with continuous administration of 1 mg.kg‐1.hr‐1 for 75 minutes
Trial: 9852693
Drug: No mexiletine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No mexiletine administration
Trial: 28099357
Drug: bilayered negative
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bilayered negative pressure wound therapy (b‐NPWT) applied to thigh incision for 5 days
Trial: 26581899
Drug: Fatigue, Age,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fatigue, Age, Fat Mass, Cancer Treatment Status
Trial: 24152215
Drug: Control (sham-treatment)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (sham-treatment) group with inert neck device for 1 week
Trial: 22265220
Drug: Intraperitoneal irrigation
RxNorm normalized name: Intraperitoneal Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal irrigation with a solution of 240 mg gentamicin and 600 mg clindamycin
Trial: 17402993
Drug: pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: pegylated interferon alpha2a (40 kDa) 180 microg/week plus ribavirin 1000/1200 mg/day for 48 weeks
Trial: 15806621
Drug: Chemotherapy regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy regimen 1
Trial: 15806621
Drug: Chemotherapy regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy regimen 2
Trial: 15806621
Drug: Multi-stage chemotherapy
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-stage chemotherapy
Trial: 12096303
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) using photosensitizers activated by light
Trial: 12096303
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PDT with other established modalities
Trial: 12096303
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of photosensitizers for endoscopic diagnosis and treatment guidance
Trial: 9802531
Drug: Alcohol (0.56
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.56 g/kg)
Trial: 9593798
Drug: Capsaicin cream
RxNorm normalized name: CAPSAICIN 0.1 g in 100 g TOPICAL CREAM [Capsaicin Cream]
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin cream (1.5 g, 1%) applied for 15 min
Trial: 9593798
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream applied for 15 min
Trial: 29660005
Drug: Cabozantinib 100
RxNorm normalized name: cabozantinib 100 MG Daily Dose Carton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabozantinib 100 mg/day
Trial: 28935146
Drug: Dark chocolate
RxNorm normalized name: Ensure Original Dark Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dark chocolate (65 g, 2148 mg polyphenols)
Trial: 28935146
Drug: Mate tea
RxNorm normalized name: Quarter Mate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mate tea (3 g, 107 mg total phenols, 84.24 mg chlorogenic acid)
Trial: 18806764
Drug: LDL apheresis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL apheresis (LA) combined with conventional therapy (CT)
Trial: 18806764
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (CT) only
Trial: 15161800
Drug: Early insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early insulin response (EIR)
Trial: 15161800
Drug: Insulin sensitivity
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin sensitivity index (S(i))
Trial: 7659484
Drug: Whole‐cell vaccines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole‐cell vaccines
Trial: 7659484
Drug: One vaccine
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One vaccine without detectable FIM
Trial: 2695280
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg bd (n = 6)
Trial: 26938814
Drug: Chlorthalidone/amiloride (12.5/2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone/amiloride (12.5/2.5 mg)
Trial: 28225315
Drug: Collaborative interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Collaborative interventions including standardized insulin infusion protocols, hypoglycemia prevention bundles, audit and feedback, education, and measure‐vention
Trial: 26439577
Drug: Chamomilla L.,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamomilla L., Melissa Officinalis L. and tyndallized Lactobacillus Acidophilus (H122) (Group A; n = 45)
Trial: 24386561
Drug: Pitavastatin 2mg
RxNorm normalized name: PITAVASTATIN 2MG TAB
DrugBank: Pitavastatin (DB08860)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pitavastatin 2mg once daily for 4 weeks
Trial: 9304176
Drug: Captopril (CTP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (CTP group, n = 15), 12.5 mg every 8 hours orally, from 24 hours before surgery
Trial: 1253193
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg practolol administered orally
Trial: 1253193
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg practolol, iv
Trial: 22921454
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT), 12 sessions
Trial: 15462115
Drug: Purified omega-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified omega-3 fatty acids (PFA) at a very low dose (0.85 g EPA and 0.57 g PHA)
Trial: 9241099
Drug: Perindopril (2‐4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (2‐4 mg daily)
Trial: 3760480
Drug: Intravenous chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous chemotherapy with Adriamycin, Vincaleucoblastin, Bleomycin, Fluorouracil and Ifosfamid monthly for 10 months
Trial: 3760480
Drug: Combined intravenous
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined intravenous and intraperitoneal chemotherapy with the same drugs
Trial: 26482056
Drug: Cholinesterase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholinesterase inhibitors (ChEIs) continuation
Trial: 15892403
Drug: suxamethonium (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: suxamethonium (1 mg kg(‐1))
Trial: 12590430
Drug: Hospital therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital therapy without methadone
Trial: 10593465
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia (EPI) with bolus doses of morphine via an epidural catheter
Trial: 10593465
Drug: Intraarticular analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular analgesia (IA) with 1 mg of morphine applied at the end of the operation and subsequent PCA
Trial: 10593465
Drug: Intravenous analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous analgesia (Control) with PCA only
Trial: 7159688
Drug: Hydrochlorothiazide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (50 mg oral dose) from Brand A
Trial: 7159688
Drug: Hydrochlorothiazide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (50 mg oral dose) from Brand B
Trial: 24611906
Drug: Fucoidan (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fucoidan (500 mg once daily before breakfast for 3 months)
Trial: 11409222
Drug: Proportional assist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proportional assist ventilation (PAV) with 9.8 (± 2.1) cm H2O/L and 3.3 (± 1.0) cm H2O/L/sec of volume assist and flow assist
Trial: 1233250
Drug: Strophanthin K
RxNorm normalized name: Effer-K
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strophanthin K (0.125 and 0.25 MG)
Trial: 1233250
Drug: Lanatoside C
RxNorm normalized name: lanatoside C
DrugBank: Lanatoside C (DB13467)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanatoside C (0.4, 0.8 and 1.6 mg)
Trial: 25406300
Drug: Autologous bone
RxNorm normalized name: Human autologous bone marrow derived osteoblastic cells
DrugBank: Human autologous bone marrow derived osteoblastic cells (DB18259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous bone marrow mononuclear cell (BMC) therapy
Trial: 18290996
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg abacavir
Trial: 18290996
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg nevirapine
Trial: 16404741
Drug: DVd (pegylated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DVd (pegylated liposomal doxorubicin 40 mg/m², vincristine 1.4 mg/m², dexamethasone 40 mg Days 1-4)
Trial: 16404741
Drug: VAd (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAd (conventional doxorubicin 9 mg/m² per day, vincristine 0.4 mg per day, dexamethasone reduced dose)
Trial: 14744180
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (neuroleptics)